Dale C. Van Demark and Sarah T. Hogan will speak at Mergermarket's Annual Life Sciences and Healthcare M&A Forum.
Topics will include:
- Exit opportunities for older fund vintages over the next 6-18 months
- Forecast 2017/18 dry powder deployment, sector economics and exit conditions
- When does private placement financing make sense? Prior to IPO or strategic sale?
- Challenges ahead in prepping portfolio companies for publicly traded life
- Considering recent product development failures and a thin product pipeline among biotech companies, how are portfolio managers positioning these investments?